Ian L. Natoff

500 total citations
24 papers, 360 citations indexed

About

Ian L. Natoff is a scholar working on Molecular Biology, Plant Science and Pharmacology. According to data from OpenAlex, Ian L. Natoff has authored 24 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Plant Science and 3 papers in Pharmacology. Recurrent topics in Ian L. Natoff's work include Receptor Mechanisms and Signaling (4 papers), Pesticide Exposure and Toxicity (4 papers) and Computational Drug Discovery Methods (3 papers). Ian L. Natoff is often cited by papers focused on Receptor Mechanisms and Signaling (4 papers), Pesticide Exposure and Toxicity (4 papers) and Computational Drug Discovery Methods (3 papers). Ian L. Natoff collaborates with scholars based in United Kingdom, Netherlands and Switzerland. Ian L. Natoff's co-authors include Mary F. Lockett, John Nixon, Michael Brewster, Anita T. Patel, Julius Wenger, Robert J. Francis, E. Worth, David H. Hutson, Colin T. Bedford and Antonin Kröhn and has published in prestigious journals such as FEBS Letters, Journal of Medicinal Chemistry and British Journal of Pharmacology.

In The Last Decade

Ian L. Natoff

24 papers receiving 328 citations

Peers

Ian L. Natoff

PHARM

CCM

Ronald Zech Germany

W. D. Erdmann Germany

Shoji Fujioka Japan

L Cima Italy

J. H. Wills United States

W. Vierling Germany

N. H. Creasey United States

B. A. Westfall United States

Cleci Menezes Moreira Brazil

Konradas Vitkevičius Lithuania

Ronald Zech Germany

Ian L. Natoff

132 ×1.1

213 ×2.0

149 ×2.3

PHARM

33 ×0.5

CCM

44 ×1.0

Citations per year, relative to Ian L. Natoff Ian L. Natoff (= 1×) peers Ronald Zech

Countries citing papers authored by Ian L. Natoff

Since Specialization

Citations

This map shows the geographic impact of Ian L. Natoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian L. Natoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian L. Natoff more than expected).

Fields of papers citing papers by Ian L. Natoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian L. Natoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian L. Natoff. The network helps show where Ian L. Natoff may publish in the future.

Co-authorship network of co-authors of Ian L. Natoff

This figure shows the co-authorship network connecting the top 25 collaborators of Ian L. Natoff. A scholar is included among the top collaborators of Ian L. Natoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian L. Natoff. Ian L. Natoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Natoff, Ian L., et al.. (1990). Cilazapril. Cardiovascular Drug Reviews. 8(1). 1–24. 10 indexed citations

Natoff, Ian L.. (1987). Preclinical studies on angiotensin converting enzyme inhibitors. Cardiovascular Drugs and Therapy. 1(1). 15–27. 5 indexed citations

Natoff, Ian L., John Nixon, Robert J. Francis, et al.. (1985). Biological Properties of the Angiotensin-Converting Enzyme Inhibitor Cilazapril. Journal of Cardiovascular Pharmacology. 7(3). 569–580. 64 indexed citations

Natoff, Ian L., Michael Brewster, & Anita T. Patel. (1981). Method for measuring the duration of inhibition of angiotensin I-converting enzyme in vivo. Journal of Pharmacological Methods. 5(4). 305–312. 6 indexed citations

Nicholson, C. D., et al.. (1979). The IN VIVO examination of the irreversible ?-adrenoceptor antagonist Ro 03-7894 on cardiac rate and contractility. Clinical and Experimental Pharmacology and Physiology. 6(6). 599–609. 7 indexed citations

Armstrong, J. M., et al.. (1979). Autonomic pharmacology: Report of the main working party. Pharmacology & Therapeutics. 5(1-3). 9–48. 6 indexed citations

Blaber, L.C., et al.. (1979). A simple method for recording left ventricular pressure dP/dt and heart rate in the conscious cat. Pharmacology & Therapeutics. 5(1-3). 99–102. 8 indexed citations

Bedford, Colin T., David H. Hutson, & Ian L. Natoff. (1975). The acute toxicity of endrin and its metabolites to rats. Toxicology and Applied Pharmacology. 33(1). 115–121. 19 indexed citations

Natoff, Ian L., et al.. (1973). Effect of oximes on the acute toxicity of anticholinesterase carbamates. Toxicology and Applied Pharmacology. 25(4). 569–575. 53 indexed citations

10.

Natoff, Ian L.. (1971). 1 Organophosphorus Pesticides: Pharmacology. Progress in medicinal chemistry. 8(1). 1–37. 15 indexed citations

11.

Natoff, Ian L.. (1970). Duration of effect of atropine sulphate against the toxicity of oxotremorine in mice. Journal of Pharmacy and Pharmacology. 22(2). 133–134. 3 indexed citations

12.

Natoff, Ian L., et al.. (1970). PROCEEDINGS OF THE BRITISH PHARMACOLOGICAL SOCIETY: 5th‐6thJANUARY, 1970. British Journal of Pharmacology. 38(2). 433P–434P. 1 indexed citations

13.

Natoff, Ian L., et al.. (1970). Quantitative studies of the effect of antagonists on the acute toxicity of organophosphates in rats. British Journal of Pharmacology. 40(1). 124–134. 16 indexed citations

14.

Natoff, Ian L.. (1969). The pharmacology of the cholinoceptor in muscle preparations of Ascaris lumbricoides var. suum. British Journal of Pharmacology. 37(1). 251–257. 42 indexed citations

15.

Natoff, Ian L.. (1967). Influence of the route of administration on the toxicity of some cholinesterase inhibitors. Journal of Pharmacy and Pharmacology. 19(9). 612–616. 14 indexed citations

16.

Barron, Denís, et al.. (1965). PHARMACOLOGY OF N‐[2‐(2,6‐XYLYLOXY)ETHYL]‐GUANIDINE SULPHATE; AN ADRENERGIC NEURONE BLOCKING AGENT. British Journal of Pharmacology and Chemotherapy. 25(2). 534–544. 1 indexed citations

17.

Barron, Denís, et al.. (1965). Pharmacological properties of 3-dimethylamino-2-methyl-1-phenyl-1-o-tolylpropanol (SK&F 70463-A). Journal of Pharmacy and Pharmacology. 17(8). 509–516. 3 indexed citations

18.

Barron, Denís, et al.. (1965). Compounds Affecting the Central Nervous System. III. Substituted 1,1-Diaryl-t-aminopropanols and Related Compounds. Journal of Medicinal Chemistry. 8(6). 836–841. 1 indexed citations

19.

Lockett, Mary F. & Ian L. Natoff. (1960). A Study of the Toxicity of Sulphite. I. Journal of Pharmacy and Pharmacology. 12(1). 488–496. 20 indexed citations

20.

Natoff, Ian L. & Mary F. Lockett. (1957). The Assay of Histamine, 5-Hydroxytryptamine, Adrenaline, and Noradrenaline, on the Blood Pressure of the Fowl. Journal of Pharmacy and Pharmacology. 9(1). 464–468. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact